Does CYTARABINE Cause Myelosuppression? 1,869 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,869 reports of Myelosuppression have been filed in association with CYTARABINE (cytarabine). This represents 4.2% of all adverse event reports for CYTARABINE.
1,869
Reports of Myelosuppression with CYTARABINE
4.2%
of all CYTARABINE reports
107
Deaths
1,017
Hospitalizations
How Dangerous Is Myelosuppression From CYTARABINE?
Of the 1,869 reports, 107 (5.7%) resulted in death, 1,017 (54.4%) required hospitalization, and 332 (17.8%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 1,869 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Product use in unapproved indication (1,619)
Pancytopenia (1,596)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
METHOTREXATE (1,523)
Which CYTARABINE Alternatives Have Lower Myelosuppression Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB